The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
KMT Legislator Lo Chih-chiang joins race for party chair
08/25/2025 09:37 PM - Sports
Team Taiwan names coaches for 2026 World Baseball Classic
08/25/2025 09:31 PM - Society
Chunghwa Post suspends small parcel services to U.S. due to tariffs
08/25/2025 08:37 PM - Cross-Strait
Taiwan's Coast Guard shadows trespassing Chinese ships off Kinmen
08/25/2025 07:38 PM - Business
NDC calls for deeper Taiwan-Japan collaboration on innovation
08/25/2025 07:30 PM